Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Registry Study to Evaluate the Performance of the BDX-XL2 Test

NCT03766958 is registered in ClinicalTrials.gov with Biodesix, Inc. as lead sponsor.

NCT NCT03766958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03766958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Registry Study to Evaluate the Performance of the BDX-XL2 Test
Lead sponsor
Biodesix, Inc.
Phase
Observational
Overall status
Completed
Start date
October 16, 2018
Completion date
May 23, 2024
Enrollment
842 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

nodule solitary pulmonary, nsclc